We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-1.88%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$3.73B
AUM Growth
-$641M
Cap. Flow
-$442M
Cap. Flow %
-11.83%
Top 10 Hldgs %
5.17%
Holding
1,489
New
168
Increased
277
Reduced
362
Closed
84

Top Sells

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$18.8M
2
WAT icon
Waters Corp
WAT
+$15.6M
3
CMI icon
Cummins
CMI
+$15.3M
4
CI icon
Cigna
CI
+$15.1M
5
AMP icon
Ameriprise Financial
AMP
+$13.2M

Sector Composition

Rank Sector Weight
1 Financials 27.38%
2 Energy 11.53%
3 Industrials 10.56%
4 Consumer Discretionary 10.28%
5 Technology 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NECB icon
1101
Northeast Community Bancorp
NECB
$367M
$237K 0.01%
+19,100
New +$239K
PYXS icon
1102
Pyxis Oncology
PYXS
$236M
$237K 0.01%
120,295
+50,000
+71% +$131K
TCRR
1103
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$237K 0.01%
131,810
+33,410
+34% +$96.9K
EQ icon
1104
Equillium
EQ
$133M
$236K 0.01%
106,200
MXC icon
1105
Mexco Energy
MXC
$19M
$236K 0.01%
14,568
CYT
1106
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$230K 0.01%
119,584
+50,000
+72% +$130K
RMCF icon
1107
Rocky Mountain Chocolate Factory
RMCF
$7.84M
$229K 0.01%
38,100
KLR
1108
DELISTED
Kaleyra, Inc.
KLR
$229K 0.01%
67,400
+14,286
+27% +$94K
MYO icon
1109
Myomo
MYO
$56.2M
$228K 0.01%
140,510
ISO
1110
DELISTED
IsoPlexis Corporation Common Stock
ISO
$228K 0.01%
132,464
+115,000
+658% +$284K
KINS icon
1111
Kingstone Companies
KINS
$276M
$227K 0.01%
85,500
QMCO icon
1112
Quantum Corp
QMCO
$474M
$227K 0.01%
+10,500
New +$337K
DXYN
1113
DELISTED
Dixie Group Inc
DXYN
$227K 0.01%
210,200
HBB icon
1114
Hamilton Beach Brands
HBB
$422M
$225K 0.01%
19,300
-14,400
-43% -$172K
OYST
1115
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$225K 0.01%
40,000
CHRA
1116
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$225K 0.01%
12,270
SSY
1117
DELISTED
SunLink Health Systems
SSY
$223K 0.01%
232,800
ESP icon
1118
Espey Mfg & Electronics Corp
ESP
$187M
$222K 0.01%
16,108
RPID icon
1119
Rapid Micro Biosystems
RPID
$86.2M
$221K 0.01%
68,500
+40,000
+140% +$155K
SBFM
1120
Sunshine Biopharma
SBFM
$2.93M
$221K 0.01%
14
-14
-50% -$304K
SVT
1121
DELISTED
Servotronics
SVT
$221K 0.01%
19,653
XLO icon
1122
Xilio Therapeutics
XLO
$60.3M
$221K 0.01%
+5,434
New +$211K
IRBT
1123
DELISTED
iRobot
IRBT
$220K 0.01%
+3,900
New +$205K
EVLO
1124
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$220K 0.01%
+5,265
New +$241K
SYBX
1125
DELISTED
Synlogic
SYBX
$219K 0.01%
15,333

Similar funds

Bridgeway Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Bridgeway Capital Management held 1,489 positions worth $3.73B, down 15% from $4.38B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.

Bridgeway Capital Management withdrew a net $442M in Q3 2022, closing 84 positions and reducing 362 holdings. Its most notable exit was L3Harris, an estimated $18.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

Against the trend, Bridgeway Capital Management opened a new position in Cleveland-Cliffs worth $11M.

  • Bridgeway Capital Management's largest Q3 2022 buy was Cleveland-Cliffs: 819,000 shares worth $11M.
  • Bridgeway Capital Management added most to Meta Platforms (Facebook) in Q3 2022, an estimated $13.9M increase.
  • Bridgeway Capital Management's biggest Q3 2022 reduction was Waters Corp, cutting an estimated $15.6M.
  • Bridgeway Capital Management fully exited L3Harris in Q3 2022, selling an estimated $18.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.2% of its $3.73B portfolio in Q3 2022.
  • Bridgeway Capital Management opened 168 new positions and closed 84 in Q3 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $3.73B.

Based on Bridgeway Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.